Plain-English translation of NCT06677840 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a probiotic called Clostridium butyricum GKB7 to see if it can help improve symptoms in children with autism spectrum disorder. Researchers believe there may be a connection between gut bacteria and how the brain functions in autism, so this medication is designed to support healthy gut bacteria. The study will measure changes in autism symptoms, thinking abilities, brain activity, and gut health over three months.
Recent research suggests that gut health and bacteria may play a role in autism symptoms. This trial exists to find out whether improving gut bacteria with this medication can help reduce autism-related challenges and improve quality of life for children on the spectrum.
You likely qualify if…
You likely don't qualify if…
If you join this study, you and your child will visit the clinic at the beginning, after one month, after two months, and at the end (three months). At each visit, your child will complete assessments to measure autism symptoms, thinking skills, and digestive health. Your child will also have brain imaging scans and provide stool and blood samples at the start and end of the study. Some participants will receive the active probiotic medication, while others will receive a placebo (inactive pill), decided randomly.
AI-generated summary from trial data · Jul 20, 2026 · Not medical advice
Taiwan